The Boston Business Journal (Free subscription) | yesterday
Boston Scientific Corp. declined to comment Monday on news that the U.S. Supreme Court declined to hear the company’s appeal over a $703 million patent infringement award against the company. (BSX)
IPBiz (Free subscription) | 10/01/2008
Bloomberg reported on Oct. 1: Boston Scientific Corp., the leading seller of artery-opening heart stents, fell to the lowest in New York trading since January after the company and Medtronic Inc. were ordered to pay $629 million in interest to Johnson & Johnson in an 11-year patent battle.
The Minneapolis/St. Paul Business Journal (Free subscription) | 10/01/2008
Boston Scientific Corp. (NYSE:BSX) must pay $703 million to Cordis Corp. under the final judgment Tuesday from U.S. District Court in Delware. (BSX)
The Boston Business Journal (Free subscription) | 10/01/2008
Boston Scientific Corp. (NYSE:BSX) must pay $703 million to Cordis Corp. under the final judgment Tuesday from U.S. District Court in Delware. (BSX)
Boston Globe (Free subscription) | yesterday
... set for Saturday, for more than a year, since the expedition hired by Abele, a founder of Boston Scientific Corp., found the wreck, 65 years after its disappearance. A representative of the Navy's submarine force is now set to speak at the service,"This is a memorial just like a funeral service, essentially," said Susan Abele, Bruce's wife. "It will bring all the families together."After...
Denver Post (Free subscription) | 10/01/2008
Johnson & Johnson said a U.S. judge has awarded the company $1.2 billion in an 11-year patent battle with Medtronic Inc. and Boston Scientific Corp. over devices that prop open heart arteries after they're cleared of fat.
Law Blog - WSJ.com (Free subscription) | 10/01/2008
A federal judge in Delaware awarded a final judgment of $1.2 billion to Johnson & Johnson's cardiac device unit Tuesday in long-running patent-infringement cases against Boston Scientific Corp. and Medtronic Inc.
